Characterization of the binding of Fe(III) to F1ATPase from bovine heart mitochondria  by Lippe, Giovanna et al.
FEBS 16588 FEBS Letters 379 (1996) 231-235 
Characterization of the binding of Fe(III) to FIATPase from bovine heart 
mitochondria 
Giovanna Lippe a, Francesca Polizio b, Francesca Di Pancrazio a, Federica Dabbeni-Sala c, 
Nadia Bortolotti d, Alessandro Desideri b, Irene Mavelli a'* 
"Department of Biomedical Sciences and Technologies, University of Udine, Via Gervasutta 48, Udine, Italy 
blNFM-Department of Biology, University of Rome "Tor Vergata', Via della Ricerca Scientifica, Rome, Italy 
CDepartment of Pharmacology, University of Padua, Largo Meneghetti, Padua, Italy 
dCattedra di Patologia Clinica, Universit~ di Udine, Via Gervasutta 48, Udine, Italy 
Received 15 November 1995; revised version received 18 December 1995 
Abstract The binding of Fe(llI) to FIATPase purified from beef 
heart mitochondria has been characterized by chemical analyses 
and EPR spectroscopy. FiATPase binds 2 mol of Fe(III)/mol of 
protein selectively in the presence of saturating concentrations of 
ATP. In the absence of nucleotides or in the presence of either 
saturating ADP or limiting ATP concentrations, the enzyme 
binds 1 equivalent of Fe(IIl). F1ATPase pretreated with 5'-p- 
fluorosulfonylbenzoyladenosine, thatselectively modifies the non- 
catalytic sites, binds only 1 mol of Fe(IIl)/mol of protein in the 
presence of either saturating ATP or ADP. Fe(III)-loaded 
FiATPase containing either 1 or 2 equivalents of Fe(III) show 
identical EPR signals at g = 4.3. The signals are not perturbed 
by the binding of nucleotides to the enzyme while they are altered 
by phosphate addition. These results indicate that FiATPase 
contains two distinct Fe(III)-binding sites, which differ from nu- 
cleotide-binding sites, and that one of these sites is opened up for 
Fe(III) uptake by conformational changes induced by binding of 
ATP to the loose non-catalytic site. 
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1. Introduction 
F~ATPase is the catalytic omponent of FoF1ATPsynthase, 
which consists of 5 different subunits with the stoichiometry 
3~: 3fl: 1 y: 1 ~: 1 e [1]. The three ~-subunits and three fl-subunits 
are arranged alternatively around a central domain containing 
the y-subunit [2]. c~-and fl-subunits contain six nucleotide-bind- 
ing sites, three of which have a catalytic role. The other three 
sites do not rapidly exchange bound nucleotides during ATP 
hydrolysis and are referred to as non-catalytic sites. Two of the 
non-catalytic and one of the catalytic sites bind nucleotides very 
tightly with respect o the remaining three sites, which are 
named loose sites [3]. Different experimental pproaches have 
established that ATP or ADP binding induces distinct confor- 
mations of these sites, that are transmitted over long distance 
[4,51. 
Till now little is known about the properties of the metal- 
binding sites in this protein complex. In particular, mitochon- 
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drial F~ATPase is documented to have two tight [6,7] and one 
'easily exchangeable' [8]binding sites for divalent metal cations, 
that are different from the metal-nucleotide-binding s tes. How- 
ever, their location and their role are far to be completely 
elucidated. Fe(II) behaves differently from the other metals. In 
fact, beef heart FIATPase is reported to bind Fe(II) up to 2 
mol/mol of protein in the presence of ATE without displacing 
Mg(II) [6]. 
In a previous work, we reported [9] that beef heart FIATPase 
is able to bind Fe(III) up to 2 mol/mol of protein in the presence 
of saturating concentrations of ATE without affecting catalysis 
as previously shown for Fe(II) [6]. We further demonstrated 
that iron ions bound in F~ moiety mediate the oxidative inacti- 
vation of the enzyme due to treatment with H20 2 of either 
purified FoF1ATPsynthase complex [10] or intact cells [11], be- 
sides isolated F~ATPase [9]. The capacity of iron bound in the 
protein to undergo to redox-cycling with H20 2 prompted us to 
study Fe(III) binding to F~ATPase as a critical factor favouring 
the inactivation of the enzyme under peroxidative conditions. 
In fact, although iron ions do not affect per se the enzyme 
activity, they are able to react with H202, leading to site-di- 
rected generation of more oxidant radical species. Further- 
more, Fe(III) binding to F~ATPase may have a crucial role in 
mediating the oxidative attack to the enzyme complex under 
physiopathological onditions associated to overproduction of
H202 as well as to iron dismetabolism, like aging, ischemia- 
reperfusion, or iron overload. 
In this study, we characterize the Fe(III)-binding sites of beef 
heart F~ATPase by chemical analyses and EPR spectroscopy. 
In particular, the enzyme has been loaded with Fe(III) selec- 
tively affecting the occupancy of nucleotide-binding sites with 
ATP or ADP. The results indicate the presence of two iron- 
binding sites, which differ from the nucleotide-binding sites. 
One of these sites is accessible for iron only in the presence of 
an excess of ATE 
2. Materials and methods 
2. l. Materials 
ADP, ATE FSBA are obtained from Sigma; Sephadex G-50 (fine) 
is from Pharmacia; the enzymes for ATP hydrolysis are purchased from 
Boehringer Mannheim; Chelex 100 is from Bio-Rad. Commercial 
standard solutions of iron are from J.T. Baker. Centricon-30 concentra- 
tors are from Amicon. All the others chemicals used are commercial 
samples of the purest quality. 
Iron-deprived buffer solutions, prepared by treatment with metal- 
chelating resin (Chelex-100), are used in all procedures, except during 
enzyme purification and ATPase activity assay. 
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2.2. Preparations of F1ATPase 
Purified FiATPase is usually prepared from beef heart mitochondria 
according to [12]. The native enzyme contains 0.5 + 0.1 mol of iron per 
tool of protein. When specified, a F]ATPase preparation purified ac- 
cording to [13] is used, which is almost completely devoid of loose and 
tight nucleotides. 
Iron-Loose Nucleotides-Depleted F~ATPase (I-LN-DF0 is prepared 
by suspending the native enzyme in 0.25 M sucrose, 10 mM Tris-HC1 
pH 7.4. Depletion of iron is obtained by incubation with 5 mM EDTA 
pH 7.4 for 1 h at 30°C while loose-nucleotides r moval is performed 
by successive precipitations (at least 2 × ) with 50% ammonium sulfate 
or by repeated washings (at least 3 x ) through centricon-30 concentra- 
tors. 
FSBA-treated F~ATPase is obtained by treating 1 mg/ml of I-LN- 
DF~, suspended in 50 mM Tris-HC1 pH 7 containing 2 mM CDTA, 
with 1.2 mM FSBA at 25°C according to [14]. When residual activity 
is ~ 15%, the FSBA-treated enzyme is centrifuged through Sephadex 
G-50 (fine) columns in 50 mM Tris-HCl pH 7.4 and subsequently 
concentrated through centricon-30 concentrators. 
Fe(III)-loaded FIATPase is prepared by suspending I-LN-DF 1 in 
0.25 M sucrose, 10 mM Tris-HC1 pH 7.4 in the absence or in the 
presence of 4 mM ATE or 4 mM ADP, or 70 gM ATE After suitable 
standing, the suspensions are incubated at 30°C with 5-fold excess of 
FeCI 3. Fe(III) bound in the enzyme is separated from free Fe(III) by 
passage of the samples through Sephadex G-50 (fine) centrifugation 
columns equilibrated in 0.25 M sucrose, l0 mM Tris-HC1 pH 7.4 
containing or not 4 mM ATP, or 4 mM ADP, or 70 gM ATE To 
remove loose nucleotides from Fe(III)-loaded F~ATPase, the enzyme 
is passed through successive Sephadex G-50 (fine) centrifugation col- 
umns equilibrated in 0.25 sucrose, 10 mM Tris-HCl pH 7.4; whereas 
to remove also tight nucleotides, the protein is passed through a Se- 
phadex G-50 (fine) column equilibrated in 100 mM Tris-sulfate pH 8 
containing 50% glycerol [15]. 
2.3. Analytical procedures 
ATPase activity is assayed spectrophotometrically t 340 nm and 
30°C using an ATP-regenerating system [16]. Average specific activity 
of F~ATPase is 75 + 10 gmol/min/mg. 
Analysis of iron is carried out by either atomic absorption as in [9] 
and spectrophotometrically using ferene method [17]. In the former 
case, samples of the different FIATPase preparations (1-4 gM) are 
diluted 5 × with water, boiled 5 min and centrifuged 10 min at 
11,000 × g. The supernatants are added with HNO3 (0.3% w/v) before 
iron analysis. Calibration curve is made using a commercial solution 
of iron: increasing amounts of iron (0.094).36 gM) are added to the 
proper media used for the enzyme suspensions previously diluted 5 × 
with water. The iron solutions are then added with HNO 3 (0.3% w/v). 
In the latter case, iron analysis is carried out directly by adding 30 gl 
of the different enzyme preparations (10-30 gM) to 130 gl of 0.05 M 
acetate buffer pH 4.8 containing 5 M guanidine hydrochloride, 2 mM 
ferene and 30 mM ascorbic acid. Calibration curve with 1-75 gM iron 
is made using a commercial solution of iron. A good agreement between 
the two methods is obtained using either solutions of Fe(III)-ATP 
complex in 0.25 M sucrose, 10 mM Tris-HC1, 4 mM ATP pH 7.4 
(coefficient of correlation 0.99) or samples of the different enzyme 
preparations (coefficient of correlation 0.90). Therefore, chemical anal- 
ysis with ferene is preferred as it requires fewer sample manupulations. 
EPR spectra re carried out on a Bruker ESP 300 x band spectrom- 
eter operating at 9 GHz with 100 kHz field modulation equipped with 
a Bruker Low Temperature System. Fe(llI) amount bound in the en- 
zyme is calculated by double integration of the signal of Fe(III)-protein 
adduct. The resulting numerical value is compared with that obtained 
from solutions of Fe(III)-ATP complex (10-140//M). A good agree- 
ment is observed among the data obtained by EPR and by the other 
two methods used for iron analysis: values differ less than 10%. 
Nucleotides are analysed by HPLC as in [16]. Protein concentration 
is determinated asin [18]. 
3. Results and discussion 
3.1. The binding of Fe(ll l) to F1ATPase is affected by 
saturating concentrations ofATP 
F~ATPase isolated from mitochondria contains substoi- 
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Fig. 1. Effects of nucleotides on Fe(III) binding to F]ATPase. I-LN- 
DF] is suspended at 10 gM in 0.25 M sucrose, 10 mM Tris-HC1 pH 
7.4 containing 4 mM ATP (~) or 4 mM ADP (©) or 70 gM ATP (A) 
or none (0). After suitable standing, the suspensions are incubated up 
to 180 min at 30°C with 50/aM FeCI 3 and aliquots are withdrawn at 
different imes to measure Fe(IlI) bound in the enzyme. 5 min is the 
shortest ime winterval because the relatively long period of time re- 
quired to remove unbound Fe(III). Experiments are performed using 
I-LN-DF~ pretreated with FSBA, as specified under section 2, and 
incubated with FeCI3 in the presence of 4 mM ATP (m) or 4 mM ADP 
(e). The lines are only intended to show the progress of the experiments. 
Data are mean + S.D. of three different experiments in which Fe(III) 
determinations are in duplicate. 
chiometric amounts of iron (see section 2). To avoid interfer- 
ence with the endogenous iron, the interaction of FIATPase 
with Fe(III) has been carried out on an enzyme in which all the 
iron has been depleted by EDTA [9]. In addition, to avoid the 
conformational changes produced by the ATP and ADP bind- 
ing to nucleotide sites [4,19], both the unbound and loosely 
bound nucleotides have been removed from the enzyme. 
FIATPase sample so obtained is named Iron-Loose Nucleo- 
tide-Depleted FIATPase (I-LN-DF~) and contains 2.9 + 0.2 
mol of nucleotides per mol of protein, which are bound, accord- 
ing to [3], in the two tight non-catalytic sites and in the tight 
catalytic site. 
Fig. 1 shows the time course of Fe(III) binding to I-LN-DF~ 
under different conditions. Fe(III) binding never affects the 
catalytic activity of the enzyme. Addition of 5-fold excess of 
Fe(III)-Tris and no nucleotides to I -LN-DFI produces the 
binding of 1 mol of Fe(III)/mol of protein in <5 min. Addition 
of 5-fold excess of Fe(III)-nucleotide to I -LN-DF 1 previously 
incubated with either limiting concentrations of ATP (70 gM), 
able to fill selectively the catalytic sites [20], or saturating con- 
centrations of ADP (4 mM), able to fill all nucleotide sites, 
again produces the binding of 1 equivalent of Fe(III) to the 
enzyme in less than 5 min. Addition of 5-fold excess of Fe(III)- 
ATP to I -LN-DFt preincubated with saturating concentrations 
of ATP (4 mM) produces binding of 2 mol of Fe(III)/mol of 
protein as already reported [9]. In the latter case, the binding 
of Fe(III) proceeds in two distinct phases, a rapid one (5 min) 
and a slow one (60 min) in which F~ATPase binds the 1st and 
the 2nd equivalent of iron respectively. Addition of saturating 
concentrations of ATP to I -LN-DFI,  left to incubate 60 min 
with a 5-fold excess of Fe(III)-Tris, produces the binding of the 
2nd equivalent of Fe(III) to the enzyme (data not shown). 
Addition of Fe(III)-nucleotide complexes and saturating ATP 
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Fig. 2. EPR spectra of FjATPase loaded with Fe(lII). I-LN-DF~ is 
suspended at20/IM in 0.25 M sucrose, 10 mM Tris-HC1 pH 7.4 and 
incubated for 60 min at 30°C with 50 ,uM FeCI3 (C). Spectra A and B 
are obtained upon Fe([II) loading of I-LN-DF~ in the presence of 
saturating concentrations of ATP (A) or ADP (B). F~ATPase, devoid 
of both loose and tight nucleotides (nucleotide content 0.4 mol/mol), 
is suspended at 13 ~M in 0.25 M sucrose, 10 mM Tris-HCl pH 7.4 
containing 5% glycerol and incubated for 60 min at 30°C with 40/tM 
FeCI3(D). Spectra B and C are amplified two times while spectrum (D) 
is amplified three times, with respect o (A). EPR spectra of Fe(III)- 
ATP and Fe(III)-ADP are qualitatively well different from the spectra 
of Fe(III)-loaded F~ATPase (data not shown). EPR conditions: 
T = 100 K, microwave power was 20 mW, frequency -- 9.44 GHz. 
or ADP to I-LN-DF1 reacted with the nucleotide analog FSBA, 
able to selectively and irreversibly bind to the non-catalytic sites 
[14], produces the binding of only 1 mol of Fe(III)/mol of 
protein, even after 2 h incubation (Fig. 1). 
These results indicate that the 2nd Fe(III) equivalent is found 
in F~ATPase only when ATP has bound to r~on-catalytic sites, 
although the order of the addition of Fe(III) and saturating 
concentrations of ATP is not important. In fact, when these 
sites are filled with FSBA, ATP is not any more able to favor 
the binding of the 2nd equivalent of iron. 
Furthermore, Fe(III) appears able to bind to the protein in 
the presence of an excess of Mg(II). In fact, even when the 
incubation with 5-fold excess of Fe(III)-ATP is performed in 
the presence of 50-fold excess of Mg(II)-ATP, 2 mol of Fe(III)/ 
mol of protein binds to I-LN-DF~ preincubated with saturating 
concentrations of ATE 
Fig. 2 shows the EPR spectra of I-LN-DFt and of a FIATP- 
ase preparation devoid of loose and tight nucleotides, which 
have been loaded with Fe(III) in the absence or in the presence 
of nucleotides. The signal is identical in all samples, even when 
iron, provided as Fe(III)-Tris, is added to the enzyme devoid 
of nucleotides. The signal is characterized by an absorption at 
g = 4.3 due to a high spin (S = 512) Fe(III) centre in a distorted 
tetragonal ligand field. Double integration of the spectra show 
that either in the absence of nucleotides or in the presence of 
saturating ADP the enzyme has bound only half the amount 
of Fe(lII) compared with the quantity bound in the presence 
of saturating ATE in line with the data of Fig. 1. The spectra 
are not perturbed by the presence of tight and loose nucleo- 
tides, indicating that nucleotides do not directly associate to the 
metal in both sites. Then, the results of Figs. 1 and 2 clearly 
indicate that binding of ATP to non-catalytic sites is needed to 
induce the conformational changes in the enzyme structure 
making accessible the second site for Fe(lII) binding. 
Addition of large amounts of phosphate to I-LN-DF1 loaded 
with Fe(III) alters in an identical way the geometry of the two 
Fe(lII) sites. In fact, Fig. 3 shows that the same EPR spectral 
changes occur in I-LN-DFt loaded with 1 or 2 mol Fe(III)/mol 
of protein. However, phosphate does not detach the iron from 
the protein as evaluated by double integration of the EPR 
signal. 
F~ATPase contains two distinct phosphate-binding sites [21], 
one of which has been documented to be located at a catalytic 
site [22]. Since it has been reported that phosphate, under con- 
ditions comparable to those of Fig. 3, does not produce confor- 
mational changes transmitted over long distances [5,19], the 
spectral changes of the Fe(III)-protein adducts induced by 
phosphate are attributed to a direct interaction of the anion 
with the metal ions, implying that one of the two iron-binding 
sites is located in the proximity of a catalytic site. Nothing may 
be said concerning the location of the second iron centre. How- 
ever, the identity of the iron EPR spectra indicate an equal 
geometry of the two sites. It may be suggested that the second 
iron centre is located in the proximity o fa  nucleotide site, since 
inspection of the recently available X-ray structure [2] indicates 
that the surrounding of the nucleotide sites has similar geome- 
try. 
3.2. Fe(III) is a poor coJhctorJor ATP  hydrolysis catalyzed by 
FIA TPase 
The efficiency of Fe(III) compared with Mg(II) as cofactor 
for ATP hydrolysis reaction has been checked using saturating 
concentrations of ATP (2.5-8 raM) and a metal:ATP ratio of 
0.5, to avoid free metals as well as to minimize metal-free ATE 
Under these conditions, a mononuclear metal-ATP complex is 
reported to be mostly formed, even with Fe(IIl) [23]. The results 
reported in Table 1 clearly show that the ATPase activity of 
I-LN-DF~ in the presence of Fe(III) is very much lower than 
in the presence of Mg(II) and comparable to that observed in 
Table 1 
Relative capacities of Fe(III) and Mg(II) to support ATPase activity 
of FjATPase 
Metal ion in the assay ATP hydrolysis rate 
~mol/min/mg protein) 
Mg(II) 50 + 3 
Fe(III) 0.020 _+ 0.015 
None 0.008 _+ 0.003 
I-LN-DF t is suspended at0.004/.tM in 50 mM Tris-HCl pH 8, 1.25 mM 
MgC12 and 2.5 mM ATE After 1-5 min, aliquots are withdrawn, added 
with 4% perchloric acid and centrifuged 10 min at 10,000 ×g. The 
supernatants are then used for the determination f inorganic phos- 
phate as in [29]. When no metal or Fe(lII) is added to the assay mixture, 
I-LN-DF~ is 18 /,tM and ATP varies from 2.5 to 8 mM while 
Fe(III):ATP ratio is maintained 0.5:1. After 10-60 min, ali- 
quots are withdrawn, treated with 4% perchloric acid, and ATP and 
ADP in the supernatants are assayed by HPLC. Control experiments 
have shown that under these conditions F~ATPase binds 2 Fe(III) 
equivalents. Temperature is 30°C. Neither Fe(III) or Mg(II) catalyze 
non-enzymatic ATP hydrolysis. Values represent mean + S.D. of four 
experiments. 
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the absence of the metal ions. This finding excludes the produc- 
tion of a high concentration of ADP affecting the enzyme 
conformation, thereby confirming that the binding of the 2nd 
Fe(III) equivalent actually occurs because of conformational 
change induced by saturating concentrations of ATE 
The very low rate of ATP hydrolysis catalyzed by FIATPase 
in the presence of Fe(III) (Table 1) is in contrast with the result 
reported by Schuster and coworkers [24], but Fe(III) ion was 
already reported to be unable to activate FjATPase [25] be- 
cause of its ionic radius, which is too small for coordinating 
correctly the phosphate oxygens of the nucleotide. In this re- 
gard, more recently it has been reported that the metal ATP 
interactions existing in Fe(III)-ATP are very different with re- 
spect to other complexes, like Mg(II)-ATE Mn(II)-ATE etc. 
[23]. Specifically, Mg(II) and other divalent cations interact 
strongly with the phosphate moiety and indirectly with the 
adenine moiety [26]. In contrast, Fe(III) is directly coordinated 
both to the phosphate chain and the N-7 ring position of ade- 
nine [23]. 
3.3. ATP-dependent binding of Fe(IlI) is reverted by loose 
nucleotide removal whereas nucleotide replacement by the 
catalytic cycle does not affect Fe(IIl) content 
Depletion of loose nucleotides from an enzyme previously 
loaded with 2 equivalents ofFe(III) induces the loss of 1 Fe(III) 
equivalent. Further depletion of tight nucleotides does not alter 
the Fe(III) content (Table 2, part A). This result shows that 
removal of ATP from the loose non-catalytic site induces the 
loss of the 2nd Fe(III) equivalent, indicating that the conforma- 
tional changes produced by the detachment of ATP from the 
loose non-catalytic site, or by the binding of ATP to such site, 
modulate the binding of Fe(III) to the second site. In line with 
this result, is the recent finding that binding of ATP or ADP 
to such site is most responsible for the different conformations 
assumed by F~ATPase in the presence of saturating ATP or 
ADP [19]. 
Incubation of the enzyme previously loaded with 2 equiva- 
lents of Fe(III) with large quantities of Mg(II)-ATP does not 
Table 2 
Effects of nucleotide removal or replacement on Fe(III) content of 
Fe(III)-loaded FIATPase 
Sample Fe(III) content 
(mol/mol) 
(A) 
(a) 
(b) 
(c) 
(B) 
(d) 
2FE(III)-loaded F~ATPase depleted of loose 
nucleotides 1.0 _+ 0.1 
sample a depleted of tight nucleotides 0.9 + 0.1 
1FE(III)-loaded F~ATPase depleted of loose 
and tight nucleotides 0.9 _+ 0.1 
2Fe(III)-loaded F1ATPase added 
with Mg(II)-ATP t= 10min 2.0+0.1 
t=30min 2.0+0.1 
t=60min 1.9+0.1 
(A) 2Fe(III)-loaded F~ATPase and 1Fe(III)-loaded FIATPase are pre- 
pared by treating I-LN-DF z with FeC13 in presence of4 mM ATP or 
70/~M ATP, respectively. Removal of loose and tight nucleotides are 
carried out as specified under section 2: in sample anucleotide content 
is 2.9 + 0.20 while in samples b and c nucleotide content is 0.6 + 0.05 
mol/mol of protein. (B) 2Fe(III)-loaded FIATPase is suspended at 10 
,uM in 0.25 M sucrose, 10 mM Tris-HCl pH 7.4, 4 mM ATP and 
incubated with 2 mM Mg(II) for 1 h at 30°C. Data are mean + S.D. 
of three different experiments in which Fe(III) are in duplicate. 
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Fig. 3. Effects of phosphate on the line shape of the EPR spectra of 
Fe(III)-loaded F~ATPase. The samples, which had been used to obtain 
the spectra A, B and C reported inFig. 3, are thawed and incubated for 
15 min at 30°C with 10 mM inorganic phosphate. Setting conditions as 
in Fig. 3. Spectra B and C are amplified two times with respect to A. 
affect he Fe(III) content of the enzyme (Table 2, part B). This 
indicates that replacement of nucleotides bound in the enzyme 
with Mg(II)-ATP during the burst of catalytic ycle does not 
cause the displacement of Fe(III) bound in the protein, in line 
with EPR data showing that Fe(III) ions do not directly associ- 
ate to nucleotides in both sites. 
4. Conclusion 
This study demonstrates that beef heart F1ATPase contains 
two distinct iron-binding sites, which differ from the nucleo- 
tide-binding sites. One site is rapidly filled irrespective of the 
presence of nucleotides. Conversely, the second site is opened 
up for Fe(III) uptake selectively by conformational changes 
due to ATP binding to the loose non-catalytic site. Perturbation 
of the iron EPR signal by phosphate indicates that one site is 
located in the proximity of the catalytic site-binding phosphate. 
Furthermore, EPR experiments show that an equal geometry 
is exhibited by the two iron-binding sites, thus suggesting as 
location of the iron centres the region close to nucleotide- 
binding sites. The existence of two iron centres in the proximity 
of two among the six nucleotide-binding sites is in accordance 
with the inherent asymmetry of such sites [2]. In line with our 
results, it has recently been found [27] that the reticulocyte 
endosome H+-ATPase, a close cousin of the FoFiATPsynthase 
[28], contains iron-binding sites located near the nucleotide 
sites. The authors have reported evidence that such enzyme is 
involved in the pathway of iron transport across the endosomal 
membranes. Then, on the basis of the similarity of the two 
proteins as well as of the location of the iron-binding sites next 
to the nucleotide sites in both F1ATPase and H+-ATPase, the 
possibility is suggested that FoFiATPsynthase may have a role 
in the mitochondrial iron homeostasis. 
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